Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

7

Revenue 2014

GlaxoSmithKline

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of GlaxoSmithKline's 2013 sales performance.

GSK and Regeneron tap into UK Biobank resource

GSK and Regeneron tap into UK Biobank resource

UK Biobank's pool of data and samples from half a million anonymous patients will be harnessed in a new project backed by drugmakers GlaxoSmithKline and Regeneron. ... In a statement, UK Biobank said the new agreement with GlaxoSmithKline (GSK) and

Pharma's reputation on the wane, say patient groups

Pharma's reputation on the wane, say patient groups PatientView's survey also looks at individual pharma companies' reputations and this year's poll revealed that ViiV Healthcare - the HIV-focused joint venture between GlaxoSmithKline (GSK), Pfizer and Shionogi - was

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post As Targacept's president and CEO, Hill will need to refocus the firm following the termination last year of its partnership with GlaxoSmithKline – with the loss of a potential $1.5bn

Trump nominates Gottlieb to head FDA

Trump nominates Gottlieb to head FDA Gottlieb has close links with the pharma industry however, sitting on the board of several small biopharma companies as well as being an advisor to GlaxoSmithKline (GSK), and is a partner

Caldan Therapeutics appoints CEO

Caldan Therapeutics appoints CEO Prior to this, Dr Payton has been chief executive officer of both Atopix Therapeutics and Oxagen, both based in Oxfordshire, UK, and brings further industry experience from GlaxoSmithKline and Biogen.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics